Our top pick for
TotalEnergies SE is an oil & gas integrated business based in the US. TotalEnergies shares (TOT) are listed on the NYSE and all prices are listed in US Dollars. TotalEnergies employs 105,476 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$46.87|
|52-week range||$27.66 - $49.58|
|50-day moving average||$46.72|
|200-day moving average||$45.56|
|Wall St. target price||$56.25|
|Dividend yield||$3.179 (6.57%)|
|Earnings per share (TTM)||$3.04|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-12)||N/A|
|1 month (2021-09-19)||N/A|
|3 months (2021-07-19)||N/A|
|6 months (2021-04-23)||5.40%|
|1 year (2020-10-19)||N/A|
|2 years (2019-10-19)||N/A|
|3 years (2018-10-19)||N/A|
|5 years (2016-10-19)||N/A|
Valuing TotalEnergies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of TotalEnergies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
TotalEnergies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 6.914. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into TotalEnergies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
TotalEnergies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19.9 billion.
The EBITDA is a measure of a TotalEnergies's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$119.8 billion|
|Operating margin TTM||5.33%|
|Gross profit TTM||$44 billion|
|Return on assets TTM||1.5%|
|Return on equity TTM||-3.47%|
|Market capitalisation||$128 billion|
TTM: trailing 12 months
There are currently 2.6 million TotalEnergies shares held short by investors – that's known as TotalEnergies's "short interest". This figure is 29.5% down from 3.8 million last month.
There are a few different ways that this level of interest in shorting TotalEnergies shares can be evaluated.
TotalEnergies's "short interest ratio" (SIR) is the quantity of TotalEnergies shares currently shorted divided by the average quantity of TotalEnergies shares traded daily (recently around 2.0 million). TotalEnergies's SIR currently stands at 1.32. In other words for every 100,000 TotalEnergies shares traded daily on the market, roughly 1320 shares are currently held short.
However TotalEnergies's short interest can also be evaluated against the total number of TotalEnergies shares, or, against the total number of tradable TotalEnergies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case TotalEnergies's short interest could be expressed as 0% of the outstanding shares (for every 100,000 TotalEnergies shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable TotalEnergies shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against TotalEnergies.
Find out more about how you can short TotalEnergies stock.
Dividend payout ratio: 1.68% of net profits
Recently TotalEnergies has paid out, on average, around 1.68% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), TotalEnergies shareholders could enjoy a 6.41% return on their shares, in the form of dividend payments. In TotalEnergies's case, that would currently equate to about $3.179 per share.
While TotalEnergies's payout ratio might seem low, this can signify that TotalEnergies is investing more in its future growth.
TotalEnergies's most recent dividend payout was on 18 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 22 March 2021 (the "ex-dividend date").
TotalEnergies's shares were split on a 99:98 basis on 6 June 2018. So if you had owned 98 shares the day before before the split, the next day you'd have owned 99 shares. This wouldn't directly have changed the overall worth of your TotalEnergies shares – just the quantity. However, indirectly, the new 1% lower share price could have impacted the market appetite for TotalEnergies shares which in turn could have impacted TotalEnergies's share price.
Over the last 12 months, TotalEnergies's shares have ranged in value from as little as $27.6568 up to $49.5791. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while TotalEnergies's is 1.1144. This would suggest that TotalEnergies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
TotalEnergies SE operates as an integrated oil and gas company worldwide. The company operates through four segments: Exploration & Production; Integrated Gas, Renewables & Power; Refining & Chemicals; and Marketing & Services. The company's Exploration & Production segment is involved in oil and natural gas exploration and production activities in approximately 50 countries. Its Integrated Gas, Renewables & Power segment engages in the liquefied natural gas (LNG) production, shipping, trading, and regasification activities; trading of liquefied petroleum gas (LPG), petcoke and sulfur, natural gas, and electricity; transportation of natural gas; electricity production from natural gas, wind, solar, hydroelectric, and biogas sources; energy storage activities; and development and operation of biomethane production units, as well as provides energy efficiency services. The company's Refining & Chemicals segment is involved in refining petrochemicals, including olefins and aromatics; and polymer derivatives, such as polyethylene, polypropylene, polystyrene, and hydrocarbon resins, as well as biomass conversion and elastomer processing. This segment also engages in trading and shipping crude oil and petroleum products. Its Marketing & Services segment produces and sells lubricants; supplies and markets petroleum products, including bulk fuel, aviation and marine fuel, special fluids, compressed natural gas, LPG, and bitumen; and provides fuel payment solutions.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.